Novartis slaps $2M-plus price tag on newly approved gene therapy Zolgensma—and cost watchdogs approve

Industry watchers have been speculating for months about just how high Novartis would price gene therapy Zolgensma on approval—and just how payers would cover it. And with the FDA’s green light, they now have an answer. The Swiss drugmaker will roll out the drug, a one-time treatment for pediatric patients less than 2 years of… Read More: Novartis slaps $2M-plus price tag on newly approved gene therapy… »

Medical News Today: Using EEG data to diagnose Parkinson’s disease

Currently, diagnosis of Parkinson’s disease relies on a neurologist’s professional opinion. Researchers behind a new study believe that an EEG may be a more effective alternative. New research suggests that an EEG test could help diagnose Parkinson’s disease. Parkinson’s disease affects more than 10 million people worldwide, according to the Parkinson’s Foundation, but no scan… Read More: Medical News Today: Using EEG data to diagnose Parkinson’s disease »

First Mesothelioma Treatment in 15 Years Approved

May 24, 2019 — The FDA has approved the first new treatment in 15 years for an aggressive form of lung cancer. The device, the NovoTTF-100L System made by Novocure, uses electric fields to stop solid tumors from mesothelioma from dividing. Mesothelioma is a rare but aggressive cancer strongly associated with asbestos exposure. The new… Read More: First Mesothelioma Treatment in 15 Years Approved »

  1. Pages:
  3. 1
  5. 619
  6. 620
  7. 621
  8. 622
  9. 623
  10. 624
  11. 625
  13. 1820